Making sense of serotonin (5HT) and its role in common psychopathology

Common Mental Disorders in Primary Care: Essays in Honour of Professor Sir David Goldberg

Volumn , Issue , 2003, Pages 17-34

  Deakin, J F William ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85076079072     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203360934-11     Document Type: Chapter

References (39)

1. Anderson, I. and Dolan, M. (1996). Psychopathy: Neuropsychology, impulse control and serotonin. Journal of Psychopharmacology Supplement 10, A3.
2. Bickerdike, M.J., Wright, I.K. and Marsden, C.A. (1993). Social isolation attenuates rat forebrain 5-HT release induced by KCI stimulation and exposure to novel environment. Behavioural Pharmacology 4/3, 231-236.
3. Bond, A.J. and Lader, M.H. (1974). The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology 47, 211-218.
4. Campbell, D.B. (1991). Dexfenfluramine: An overview of its mechanisms of action. Reviews in Contemporary Pharmacotherapy 2, 93-113.
5. Checkley, S. (1996). The neuroendocrinology of depression and chronic stress. British Medical Bulletin 52, 597-617.
6. Connell, J., Sennef, C. and Deakin, J.F.W. (1999). The effects of ORG 12962, a 5-HT2C receptor agonist, in two models of experimentally induced anxiety in healthy female volunteers. International Journal of Neuropsychopharmacology vol. 2, Supplement 1, S136-137.
7. Coccaro, E.F., Siever, L.J., Klar, H.M., Maurer, G., Cochrane, K., Cooper, T.B., Mohrs, R.C. and Davis, K.L. (1989). Serotonergic studies in patients with affective and personality disorders; correlates with suicidal and impulsive aggressive behaviour. Archives of General Psychiatry 46, 587-599.
8. Cowen, P.J. and Charig, E.M. (1987). Neuroendocrine responses to tryptophan in major depression. Archives of General Psychiatry 44, 958-966.
9. Damasio, A.R. (1994). Descartes’ Error: Emotion, rationality and the human brain. New York, Putnam (Grosset Books).
10. Deakin, J.F.W. (1983). Roles of serotonergic systems in escape, avoidance and other behaviours. In: J.S.Cooper (ed.) Theory in Psychopharmacology. Academic Press, New York.
11. Deakin, J.F.W. (1988). 5HT2 receptors depression and anxiety. Pharmacology, Biochemistry and Behavior 29, 819-820.
12. Deakin, J.F.W. (1996). 5HT, antidepressant drugs and the psychosocial origins of depression. Journal of Psychopharmacology 10(1), 31-38.
13. Deakin, J.W.F. and Graeff, F.G. (1991). 5-HT and mechanisms of defence. Journal of Psychopharmacology 5, 305-315.
14. Deakin, J.F.W., Pennell, I., Upadhyaya, A.K. and Lofthouse, R. (1990). A neuroendocrine study of 5Ht function in depression: Evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology 101, 85-92.
15. Delgado, P.L., Charney, D.S., Price, L.H., Aghajanian, G.K., Landis, H. and Heninger, G.R. (1990). Serotonin function and the mechanism of antidepressant action. Archives of General Psychiatry 47, 411-418.
16. Dolan, R.J., Galloway, S.P., Fonagy, P., De Souza, F.V.A. and Wakeling, A. (1985). Life events, depression and hypothalamic-pituitary-adrenal axis function. British Journal of Psychiatry 147, 429-433.
17. Fulford, A.J. and Marsden, C.A. (1998). Conditioned release of 5-hydroxytryptamine in vivo in the nucleus accumbens following isolationrearing in the rat. Neuroscience 83, 481-487.
18. Goldberg, D.P. and Huxley, P. (1992). Common Mental Disorders. A Bio-social Model. Routledge, London.
19. Goodall, E., Cowan, P.J., Franklin, M. and Silverstone, T. (1993). Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology 112, 461-466.
20. Gray, J.A. (1987). The Psychology of Fear and Stress. 2nd edn. Cambridge, Cambridge University Press.
21. Guimaraes, F.S., Hellewell, J.S.E., Hensman, R., Wang, M. and Deakin, J.F.W. (1991). Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: Influence of gender, instruction, personality and placebo. Psychopharmacology 104, 231-236.
22. Hensman, R., Guimaraes, F.S., Wang, M. and Deakin, J.F.W. (1991). Effects of ritanserin on aversive classical conditioning in humans. Psychopharmacology 104, 220-224.
23. Hetem, L.A.B., De Souza, C.J., Guimaraes, F.S.G., Zuardi, A.W. and Graeff, F.G. (1993). D-fenfluramine reduces anxiety induced by simulated public speaking. Brazilian Journal of Medical and Biological Research 26, 971-974.
24. Jacobs, B.L. and Fornal, C.A. (1991). Activity of brain serotonergic neurons in the behaving animal. Pharmacological Review 43, 563-578.
25. Kavoussi, R.J., Kramer, J., Hauger, R.L. and Coccaro, E.F. (1998). Prolactin response to D-fenfluramine in outpatients with major depression. Psychiatry Research 79, 199-205.
26. Kennett, G.A., Dickinson, S.L. and Curzon, G. (1985a). Central serotonergic responses and behavioral adaptation to repeated immobilisation: The effect of the corticosterone synthesis inhibitor metyrapone. European Journal of Pharmacology 119, 143-152.
27. Kennett, G.A., Dickinson, S.L. and Curzon, G. (1985b). Enhancement of some 5-HT-dependent behavioral responses following repeated immobilization in rats. Brain Research 330, 253-263.
28. Killcross, S., Robbins, T.W. and Everitt, B.J. (1997). Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature 388, 377-380.
29. McNair, D.M., Frankenthaler, L.M., Czerlinsky, T., White, T.W., Sasson, S. and Fischer, S. (1982). Simulated public speaking as a model of clinical anxiety. Psychopharmacology 77, 7-10.
30. Meyer, J.H., Kennedy, S. and Brown, G.M. (1998). No effect of depression on [(15)O]H2O PET response to intravenous d-fenfluramine. American Journal of Psychiatry 155(9), 1241-1246.
31. Miller, H., Deakin, J.F.W. and Anderson, I.M. (1995). Acute tryptophan depletion increases panic anxiety in panic disorder patients. Journal of Psychopharmacology 9, A18.
32. Mortimore, C. and Anderson, I.M. (1998). Dexfenfluramine in panic disorder: 5Ht induces anxiety but prevents panic. Journal of Psychopharmacology 12 Suppl, A20.
33. Park, S.B., Williamson, D.J., and Cowen, P.J. (1996). 5-HT neuroendocrine function in major depression: Prolactin and cortisol responses to D-fenfluramine. Psychological Medicine 26(6), 1191-1196.
34. Rogers, R.D., Baldacchino, A., Johnson, A.J., Swainson, R., London, M., Deakin, J.F.W., Sahakian, B.J., Robbins, T.W. and Everitt, B.J. (1999). Dissociable deficits in the decision making cognition of chronic amphetamine and opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology 20, 322-339.
35. Schulz, W., Dayan, P. and Montague, P.R. (1998). A neural substrate of prediction and reward. Science 275, 1593-1599.
36. Shapira, B., Cohen, J., Newman, N.E. and Lerer, B. (1993). Prolactin response to fenfluramine and placebo. Challenge following maintenance pharmacotherapy withdrawal in remitted depressed. Biological Psychiatry 33, 531-535.
37. Targum, S.D. and Marshall, L.E. (1989). Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Research 28, 295-306.
38. Upadhyaya, A.K., Pennell, I., Cowen, P.J. and Deakin, J.F.W. (1991). Blunted growth hormone and prolactin responses to L-tryptophan in depression: A state-dependent abnormality. Journal of Affective Disorders 21, 213-218.
39. Zuardi, A.W., Cosme, R.A., Graeff, F.G. and Guimarães, F.S. (1993). Effects of ipsapirone and cannabidiol on human experimental anxiety, Journal of Psychopharmacology 7, 82-88.